Ariclaim blev til behandling af diabetiske neuropatiske smerter undersøgt i to 12- ugers undersøgelser af 809 voksne med diabetes, som havde haft smerter hver dag i de sidste seks måneder.
For the treatment of diabetic neuropathic pain, Ariclaim has been studied in two 12-week studies in 809 diabetic adults who had had pain every day for at least six months.